Independent Analyst Values Vyome’s VT-1953 at Nearly $1 Billion Post-Phase 3—Peak U.S. Sales Could Reach $600 Million
Market Chameleon (Tue, 27-Jan 9:52 AM)
Independent Analysis Sees Vyome’s VT-1953 Asset Value Approaching $1 Billion After Phase 3 Study
Market Chameleon (Tue, 27-Jan 8:20 AM)
Vyome's VT-1953 Delivers Strong Phase 2 Results: Aiming for FDA Approval in $1B Malignant Fungating Wound Market
Market Chameleon (Mon, 8-Dec 8:22 AM)
